BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
NEWARK, N.J., March 15, 2011 /PRNewswire/ -- BioNeutral Group, Inc. (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced that it has entered into a global sales and distribution agreement with Raymond Associates LLC, a Service Connected Certified Disabled Veteran-Owned Business and executive management consulting firm. Under the terms of the agreement, Raymond Associates will represent BioNeutral's Military-Grade, patent-pending antimicrobial product Ygiene™ to the homeland security and government sectors in the Middle East, the United Kingdom and the United States.
Founded by the 20-year U.S. Army Certified Disabled American Veteran Kenneth R. Curley, Raymond Associates LLC has a proven track record of securing federal government contracts worldwide. "Working with Ken presents a unique opportunity to bring Ygiene™ MG throughout the regions of the world where the ever-present threat of a biological attack and warfare persist," said Stephen J. Browand President and CEO of BioNeutral Group, Inc. "As a result of our strategic partnership, we expect to secure new orders and government contracts for our Ygiene™ Military-Grade, which can quickly neutralize a wide variety of on-the-surface, biological contaminants and extremely dangerous microorganisms."
"We are extremely proud to be representing BioNeutrals' game-changing, Military-Grade Ygiene™ technology as a cutting edge defensive counter measure in both the U.S. and abroad," stated Kenneth R. Curley , President and CEO of Raymond Associates LLC. who went on to say, "Based on the independent testing results I have seen, Ygiene™ is a highly effective disinfecting/sterilizing power that is completely non-corrosive to ferrous metals, making it ideally suited for use on planes, ships and in today's hi-tech military vehicles. The Company's recently EPA-approved Hospital-Grade Ygiene™, will undoubtedly make a positive difference once put to use in our Military and VA hospitals and other healthcare facilities."
Founder and CEO of Raymond Associates, Kenneth R. Curley , is a West Point U.S. Military Academy graduate and distinguished Army officer veteran of over 20 years. Upon retirement in 1998, Mr. Curley was selected to serve within New York State government as the Director of Military Support, followed by Chief of Staff within the Division of Military and Naval Affairs. In 2003, Mr. Curley transitioned to the Country of Iraq, as the Deputy Director of Requirements Coordination in Baghdad and then as Chief of Staff Special Projects to the Coalition Provisional Authority. In 2005, Raymond Associates supported the Emergency Response Efforts of Hurricane Katrina and Hurricane Rita. Raymond Associates was founded in 2000, and has offices in New York, Florida, Baghdad, Iraq and the United Arab Emirates.
About Raymond Associates LLC
Raymond Associates LLC is a Service Connected Disabled Veteran Owned Business that provides organizational development and executive management services in the United States, United Kingdom and the Middle East. For more information, please visit http://raymondassociatesllc.com/.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have been approved by the EPA for sale in the United States and has previously been approved for sale in Germany and it is also permitted to be sold in the UK, France and Sweden. AutoNeutral is a Registered trademark of BioNeutral Group, Inc. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutralgroup.com.
Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to Ygiene™ -206. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and will soon be available for sale in the United States.
North 6th Agency
Investor Relations Contact:
ProActive Capital Resources Group, LLC
FOR THE COMPANY:
Stephen J. Browand
BioNeutral Group, Inc.
SOURCE BioNeutral Group, Inc.
More by this Source
BioNeutral Gains Initial Market Acceptance
Feb 25, 2013, 09:00 ET
BioNeutral appoints Chairman of its Audit and Executive Compensation Committees
Dec 17, 2012, 16:12 ET
BioNeutral Enters Into Equity Purchase Agreement With Southridge Partners II
Dec 13, 2012, 15:48 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.